« Back to Record
Citation APA

Langleben, D., Christman, B. W., Barst, R. J., Dias, V. C., Galie, N., Higenbottam, T., Kneussl, M., Korducki, L., Naeije, R., Riedel, A., Simonneau, G., Hirsch, A. M., Rich, S., Robbins, I. M., Oudiz, R. J., McGoon, M., Badesch, D. B., Levy, R. D., Mehta, S., Seeger, W., & Solèr, M. (2002). Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. The American heart journal, 143(5), E4.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/89050

Langleben, D., Christman, B. W., Barst, R. J., Dias, V. C., Galie, N., Higenbottam, T., Kneussl, M., Korducki, L., Naeije, R., Riedel, A., Simonneau, G., Hirsch, A. M., Rich, S., Robbins, I. M., Oudiz, R. J., McGoon, M., Badesch, D. B., Levy, R. D., Mehta, S., Seeger, W., & Solèr, M. (2002). Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. The American heart journal, 143(5), E4.